Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.385 CAD | +1.32% |
|
+1.32% | -40.77% |
06-19 | LifeSpeak Inc. Announces Chief Financial Officer Changes | CI |
06-19 | LifeSpeak Inc. Appoints Britt Morries as Chief Technology Officer | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 306.7 | 48.43 | 33.09 | 22.77 | - |
Enterprise Value (EV) 1 | 290.6 | 131.5 | 33.09 | 96.07 | 90.87 |
P/E ratio | -8.36 x | -1 x | -1.25 x | -1.88 x | -2.41 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 13.2 x | 1.02 x | 0.63 x | 0.45 x | 0.41 x |
EV / Revenue | 12.5 x | 2.78 x | 0.63 x | 1.91 x | 1.64 x |
EV / EBITDA | 44.1 x | 15.1 x | 2.55 x | 8.68 x | 5.95 x |
EV / FCF | -25.4 x | -16.8 x | - | 18.2 x | 18 x |
FCF Yield | -3.94% | -5.96% | - | 5.48% | 5.56% |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 48,303 | 50,982 | 50,911 | 59,136 | - |
Reference price 2 | 6.350 | 0.9500 | 0.6500 | 0.3850 | 0.3850 |
Announcement Date | 22-03-22 | 23-03-31 | 24-03-21 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | - | 23.27 | 47.37 | 52.41 | 50.24 | 55.52 |
EBITDA 1 | - | 6.594 | 8.688 | 12.98 | 11.06 | 15.28 |
EBIT 1 | - | -6.605 | -15.67 | -11.68 | -3.889 | -0.961 |
Operating Margin | - | -28.39% | -33.08% | -22.28% | -7.74% | -1.73% |
Earnings before Tax (EBT) 1 | - | -27.24 | -51.35 | -31.21 | -13.14 | -9.989 |
Net income 1 | 0.0978 | -26.32 | -47.91 | -26.26 | -11.9 | -9.689 |
Net margin | - | -113.14% | -101.15% | -50.11% | -23.68% | -17.45% |
EPS 2 | - | -0.7600 | -0.9500 | -0.5200 | -0.2050 | -0.1600 |
Free Cash Flow 1 | - | -11.45 | -7.839 | - | 5.267 | 5.05 |
FCF margin | - | -49.23% | -16.55% | - | 10.48% | 9.1% |
FCF Conversion (EBITDA) | - | - | - | - | 47.61% | 33.04% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 21-06-14 | 22-03-22 | 23-03-31 | 24-03-21 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 6.838 | 8.71 | 12.14 | 12.77 | 13.76 | 13.4 | 13.16 | 12.9 | 12.95 | 12.4 | 12.48 | 12.73 | 12.81 | 13.65 | 13.7 |
EBITDA 1 | 0.941 | 0.382 | 2.412 | 3.078 | 4.816 | 3.682 | 3.336 | 3.251 | 2.717 | 2.695 | 2.576 | 2.72 | 2.83 | 3.3 | 3.5 |
EBIT 1 | -5.24 | -8.142 | -5.43 | 0.464 | -0.563 | -2.604 | -5.046 | -0.123 | -3.903 | 0.1583 | -1.583 | -1.301 | -1.144 | -0.6 | -0.4 |
Operating Margin | -76.63% | -93.48% | -44.73% | 3.63% | -4.09% | -19.44% | -38.33% | -0.95% | -30.14% | 1.28% | -12.68% | -10.23% | -8.93% | -4.4% | -2.92% |
Earnings before Tax (EBT) 1 | -7.764 | -17.46 | -6.986 | -1.81 | -25.93 | -1.249 | -7.528 | -2.674 | -19.76 | -2.318 | -3.838 | -3.589 | -3.398 | -2.5 | -2.3 |
Net income 1 | -6.846 | -16.35 | -6.457 | -1.406 | -24.54 | -0.354 | -6.251 | -1.982 | -17.68 | -1.604 | -3.667 | -3.391 | -3.237 | -2.4 | -2.1 |
Net margin | -100.12% | -187.76% | -53.19% | -11.01% | -178.43% | -2.64% | -47.49% | -15.37% | -136.5% | -12.93% | -29.37% | -26.65% | -25.27% | -17.58% | -15.33% |
EPS 2 | -0.1100 | -0.3330 | -0.1300 | -0.0300 | -0.5300 | -0.0100 | -0.1200 | -0.0390 | -0.3500 | -0.0300 | -0.0600 | -0.0600 | -0.0575 | -0.0400 | -0.0400 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 22-03-22 | 22-05-12 | 22-08-03 | 22-11-10 | 23-03-31 | 23-05-15 | 23-08-09 | 23-11-08 | 24-03-21 | 24-05-08 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 83.1 | - | 73.3 | 68.1 |
Net Cash position 1 | - | 16.1 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 9.564 x | - | 6.626 x | 4.456 x |
Free Cash Flow 1 | - | -11.5 | -7.84 | - | 5.27 | 5.05 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex | - | 0.11 | - | - | - | - |
Capex / Sales | - | 0.49% | - | - | - | - |
Announcement Date | 21-06-14 | 22-03-22 | 23-03-31 | 24-03-21 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.77% | 16.56M | |
+35.72% | 394B | |
+32.12% | 231B | |
+11.67% | 162B | |
+19.99% | 60.77B | |
+28.57% | 36.98B | |
+2.07% | 30.2B | |
+116.26% | 24.23B | |
+26.40% | 20.92B | |
+39.43% | 14.13B |
- Stock Market
- Equities
- LSPK Stock
- Financials LifeSpeak Inc.